Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Invitation to presentation of MEDS 2025 year-end report on February 10, 2026

MEDS will publish its 2025 year-end report on February 10, 2026, at 07:30 CET. A webcast presentation will be held for analysts, media, and investors at 09:30 CET the same day.

The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.

The presentation will be conducted in English and broadcast live online. Please email ir@meds.se  to receive a link to the live presentation (at latest 09:00 CET on 10th of February).

A recorded version of the presentation will be available later at: Rapporter och presentationer | MEDS Investor Relations
 
Schedule for the 10th of February:

  • 07:30 CET – Publication of the Q4 report
  • 9:30 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola

 
For further information, please contact:
Frida Benno Hjerpe
MEDS Press & Investor Relations
E-mail: press@meds.se
Web: https://corporate.meds.se/

About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.

Certified advisor is FNCA.